LAB STANDARD BIOTOOLS INC.
Nasdaq · SEC CIK 1162194 · EDGAR
- Bought, last 12 months
- $14.41M 5 purchases by 4 insiders
- Sold, last 12 months
- $0 0 sales by 0 insiders
- Filings on record
- 174 since 2021-08-24, latest 2026-08-24 17:06
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Casdin Partners GP, LLC | Dir, 10% | $11.41M | — |
| Casdin Eli | Dir, 10% | $1.37M | — |
| Casdin Partners Master Fund, L.P. | Dir, 10% | $1.12M | — |
| CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC | Dir | $503.0K | — |
| Kim Hanjoon Alex | CFO | — | — |
| Mackay Sean | SVP, Chief Business Off | — | — |
| Cox Troy | Dir | — | — |
| Carey Thomas D. | Dir | — | — |
| Egholm Michael | Pres, CEO, Dir | — | — |
| Witney Frank | Dir | — | — |
Transactions 201
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-05-21 | 2024-05-20 | LAB | Kim Hanjoon Alex | COO | A - Grant | $0.00 | +333.3K | 544.4K | +158% | $0 |
| D | 2024-05-21 | 2024-05-20 | LAB | Black Jeffrey G. | SVP, CFO | A - Grant | $0.00 | +300.0K | 419.8K | +250% | $0 |
| MI | 2024-05-17 | 2024-05-15+ | LAB | Casdin Eli | Dir, 10% | P - Purchase | $2.56 | +1.35M | 45.38M | +3% | +$3.46M |
| D | 2024-05-16 | 2024-05-15 | LAB | Black Jeffrey G. | SVP, CFO | F - Tax | $2.54 | -18.8K | 119.8K | -14% | -$47.7K |
| D | 2024-05-16 | 2024-05-15 | LAB | Black Jeffrey G. | SVP, CFO | M - OptEx | $0.00 | +52.6K | 138.6K | +61% | $0 |
| 2024-04-09 | 2024-04-08 | LAB | Egholm Michael | Pres, CEO, Dir | F - Tax | $2.71 | -102.6K | 531.6K | -16% | -$277.9K | |
| D | 2024-04-05 | 2024-04-05 | LAB | Kim Hanjoon Alex | COO | A - Grant | $0.00 | +70.7K | 211.1K | +50% | $0 |
| D | 2024-04-05 | 2024-04-04 | LAB | Kim Hanjoon Alex | COO | M - OptEx | $0.00 | +70.2K | 140.4K | +100% | $0 |
| DM | 2024-04-05 | 2024-01-05+ | LAB | Egholm Michael | Pres, CEO, Dir | A - Grant | $0.00 | +221.1K | 634.2K | +54% | $0 |
| D | 2024-04-05 | 2024-04-04 | LAB | Egholm Michael | Pres, CEO, Dir | M - OptEx | $0.00 | +196.5K | 422.0K | +87% | $0 |
| DMI | 2024-03-20 | 2024-03-18 | LAB | Casdin Partners GP, LLC | Dir, 10% | A - Grant | $2.75 | +46.47M | 13.94M | New | +$127.78M |
| M | 2024-03-06 | 2024-03-04+ | LAB | Casdin Private Growth Equity Fund II GP, LLC | Dir | P - Purchase | $2.57 | +251.4K | 11.50M | +2% | +$646.2K |
| 2024-02-22 | 2024-02-20 | LAB | Casdin Eli | Dir, 10% | A - Grant | $2.50 | +22.8K | 103.6K | +28% | +$57.0K | |
| 2024-01-09 | 2024-01-05 | LAB | Casdin Partners GP, LLC | Dir, 10% | A - Grant | — | +11.25M | 11.25M | New | — | |
| I | 2024-01-09 | 2024-01-05 | LAB | Casdin Partners GP, LLC | Dir, 10% | A - Grant | — | +2.74M | 2.74M | New | — |
| D | 2024-01-09 | 2024-01-05 | LAB | HIBBS KATHY L | Dir | A - Grant | $0.00 | +79.4K | 79.4K | New | $0 |
| DM | 2024-01-09 | 2024-01-05 | LAB | Cox Troy | Dir | A - Grant | $0.00 | +198.1K | 166.5K | New | $0 |
| DMI | 2024-01-09 | 2024-01-05 | LAB | Casdin Eli | Dir, 10% | A - Grant | — | +21.54M | 7.55M | New | — |
| DM | 2024-01-09 | 2024-01-05 | LAB | Casdin Eli | Dir, 10% | A - Grant | — | +7,614 | 80.8K | +10% | — |
| D | 2024-01-09 | 2024-01-05 | LAB | Carey Thomas D. | Dir | A - Grant | $0.00 | +79.4K | 79.4K | New | $0 |
| 2023-10-20 | 2023-10-20 | LAB | Madaus Martin D | Dir | A - Grant | $2.54 | +1,574 | 104.1K | +2% | +$3,998 | |
| MI | 2023-07-03 | 2023-06-29+ | LAB | JOHNSON DAVID EDWARD | 10% | J - Other | — | -779.3K | 7.80M | -9% | — |
| D | 2023-06-16 | 2023-06-14 | LAB | Witney Frank | Dir | A - Grant | $0.00 | +26.4K | 73.1K | +56% | $0 |
| D | 2023-06-16 | 2023-06-14 | LAB | Madaus Martin D | Dir | A - Grant | $0.00 | +26.4K | 102.5K | +35% | $0 |
| D | 2023-06-16 | 2023-06-14 | LAB | Clague Laura | Dir | A - Grant | $0.00 | +26.4K | 104.8K | +34% | $0 |
| D | 2023-06-16 | 2023-06-14 | LAB | ELOI FENEL M | Dir | A - Grant | $0.00 | +26.4K | 98.5K | +37% | $0 |
| D | 2023-06-16 | 2023-06-14 | LAB | Paya Carlos V | Dir | A - Grant | $0.00 | +26.4K | 126.8K | +26% | $0 |
| D | 2023-06-16 | 2023-06-14 | LAB | Casdin Eli | Dir | A - Grant | $0.00 | +26.4K | 73.1K | +56% | $0 |
| M | 2023-05-22 | 2023-05-18+ | LAB | Black Jeffrey G. | SVP, CFO | P - Purchase | $2.25 | +86.0K | 43.5K | New | +$193.9K |
| MI | 2023-05-19 | 2023-05-17+ | LAB | Casdin Eli | Dir, 10% | P - Purchase | $2.19 | +1.20M | 1.20M | New | +$2.63M |
| MI | 2023-05-19 | 2023-05-17+ | LAB | Casdin Private Growth Equity Fund II GP, LLC | Dir | P - Purchase | $2.19 | +1.20M | 1.20M | New | +$2.63M |
| D | 2023-04-06 | 2023-04-04 | LAB | Kim Hanjoon Alex | COO | M - OptEx | $0.00 | +70.2K | 70.2K | New | $0 |
| D | 2023-04-06 | 2023-04-04 | LAB | Egholm Michael | Pres, CEO, Dir | M - OptEx | $0.00 | +196.5K | 206.5K | +1,965% | $0 |
| 2023-03-17 | 2023-03-15 | LAB | ELOI FENEL M | Dir | A - Grant | $0.00 | +72.1K | 72.1K | New | $0 | |
| D | 2023-02-23 | 2023-02-21 | LAB | Davis Jeremy Steven | SVP Chief Commercial Off | M - OptEx | $0.00 | +20.8K | 20.8K | New | $0 |
| D | 2023-02-23 | 2023-02-21 | LAB | Davis Jeremy Steven | SVP Chief Commercial Off | F - Tax | $2.03 | -6,176 | 14.7K | -30% | -$12.5K |
| DM | 2023-02-23 | 2023-02-21 | LAB | JOG VIKRAM | CFO | M - OptEx | $0.00 | +74.4K | 246.3K | +43% | $0 |
| D | 2023-02-23 | 2023-02-21 | LAB | JOG VIKRAM | CFO | F - Tax | $2.03 | -28.7K | 217.6K | -12% | -$58.3K |
| 2023-02-22 | 2023-02-20 | LAB | Madaus Martin D | Dir | A - Grant | $0.00 | +29.7K | 76.2K | +64% | $0 | |
| I | 2022-12-30 | 2022-12-29 | LAB | Caligan Partners LP | 10% | J - Other | — | -2.87M | 8.58M | -25% | — |
| DM | 2022-11-22 | 2022-11-21 | LAB | JOG VIKRAM | CFO | M - OptEx | $0.00 | +7,759 | 174.6K | +5% | $0 |
| D | 2022-11-22 | 2022-11-21 | LAB | JOG VIKRAM | CFO | F - Tax | $1.43 | -2,681 | 171.9K | -2% | -$3,834 |
| DM | 2022-08-24 | 2022-08-22 | LAB | JOG VIKRAM | CFO | M - OptEx | $0.00 | +7,756 | 169.5K | +5% | $0 |
| D | 2022-08-24 | 2022-08-22 | LAB | JOG VIKRAM | CFO | F - Tax | $1.56 | -2,681 | 166.8K | -2% | -$4,182 |
| MI | 2022-08-05 | 2022-08-03+ | LAB | JOHNSON DAVID EDWARD | 10% | P - Purchase | $1.75 | +301.2K | 11.44M | +3% | +$526.6K |
| MI | 2022-08-02 | 2022-07-29+ | LAB | JOHNSON DAVID EDWARD | 10% | P - Purchase | $1.54 | +620.5K | 10.87M | +6% | +$953.6K |
| D | 2022-06-17 | 2022-06-15 | LAB | Madaus Martin D | Dir | A - Grant | $0.00 | +30.9K | 46.8K | +195% | $0 |
| D | 2022-06-17 | 2022-06-15 | LAB | Clague Laura | Dir | A - Grant | $0.00 | +30.9K | 78.4K | +65% | $0 |
| D | 2022-06-17 | 2022-06-15 | LAB | Casdin Eli | Dir | A - Grant | $0.00 | +30.9K | 46.8K | +195% | $0 |
| D | 2022-06-17 | 2022-06-15 | LAB | Colston Bill | Dir | A - Grant | $0.00 | +30.9K | 59.3K | +109% | $0 |
| D | 2022-06-17 | 2022-06-15 | LAB | Burbach Gerhard F | Dir | A - Grant | $0.00 | +30.9K | 96.8K | +47% | $0 |
| D | 2022-06-17 | 2022-06-15 | LAB | Paya Carlos V | Dir | A - Grant | $0.00 | +30.9K | 100.5K | +44% | $0 |
| D | 2022-06-17 | 2022-06-15 | LAB | Witney Frank | Dir | A - Grant | $0.00 | +30.9K | 46.8K | +195% | $0 |
| I | 2022-06-15 | 2022-06-13 | LAB | Caligan Partners LP | 10%, See Remarks | P - Purchase | $1.70 | +100.0K | 10.52M | +1.0% | +$170.0K |
| MI | 2022-06-06 | 2022-06-02+ | LAB | JOHNSON DAVID EDWARD | 10% | P - Purchase | $1.95 | +450.0K | 10.17M | +5% | +$879.0K |
| 2022-06-03 | 2022-05-31 | LAB | Khadder Nicholas | SVP, Gen. Counsel, Sec | A - Grant | $1.61 | +3,341 | 100.5K | +3% | +$5,379 | |
| DM | 2022-05-23 | 2022-05-20 | LAB | Kreger Bradley Allen | SVP, Gbl Ops | M - OptEx | $0.00 | +42.3K | 99.1K | +74% | $0 |
| D | 2022-05-23 | 2022-05-20 | LAB | Kreger Bradley Allen | SVP, Gbl Ops | F - Tax | $2.05 | -14.4K | 119.2K | -11% | -$29.6K |
| D | 2022-05-23 | 2022-05-20 | LAB | Khadder Nicholas | SVP, Gen. Counsel, Sec | F - Tax | $0.00 | -14.2K | 97.1K | -13% | $0 |
| DM | 2022-05-23 | 2022-05-20 | LAB | Khadder Nicholas | SVP, Gen. Counsel, Sec | M - OptEx | $0.00 | +28.9K | 86.5K | +50% | $0 |
| DM | 2022-05-23 | 2022-05-20 | LAB | JOG VIKRAM | CFO | M - OptEx | $0.00 | +41.9K | 136.5K | +44% | $0 |
| D | 2022-05-23 | 2022-05-20 | LAB | JOG VIKRAM | CFO | F - Tax | $2.05 | -14.4K | 161.8K | -8% | -$29.4K |
| MI | 2022-05-10 | 2022-05-06+ | LAB | Caligan Partners LP | 10% | P - Purchase | $2.88 | +488.4K | 9.95M | +5% | +$1.41M |
| MI | 2022-05-02 | 2022-04-28+ | LAB | JOHNSON DAVID EDWARD | 10% | P - Purchase | $2.69 | +400.0K | 9.36M | +4% | +$1.08M |
| MI | 2022-04-13 | 2022-04-11+ | LAB | Caligan Partners LP | 10% | P - Purchase | $3.80 | +195.0K | 9.03M | +2% | +$741.1K |
| MI | 2022-04-08 | 2022-04-06+ | LAB | Caligan Partners LP | 10% | P - Purchase | $3.77 | +509.6K | 8.69M | +6% | +$1.92M |
| D | 2022-04-06 | 2022-04-04 | LAB | Casdin Eli | Dir, 10% | A - Grant | $0.00 | +15.9K | 15.9K | New | $0 |
| D | 2022-04-06 | 2022-04-04 | LAB | Madaus Martin D | Dir | A - Grant | $0.00 | +15.9K | 15.9K | New | $0 |
| D | 2022-04-06 | 2022-04-04 | LAB | Witney Frank | Dir | A - Grant | $0.00 | +15.9K | 15.9K | New | $0 |
| DI | 2022-04-04 | 2022-04-01 | LAB | BARTHELEMY NICOLAS | Dir | M - OptEx | $3.74 | +21.0K | 204.1K | +11% | +$78.5K |
| DI | 2022-04-01 | 2022-03-31 | LAB | BARTHELEMY NICOLAS | Dir | M - OptEx | $3.43 | +5,000 | 183.1K | +3% | +$17.1K |
| DM | 2022-02-24 | 2022-02-22 | LAB | JOG VIKRAM | CFO | M - OptEx | $0.00 | +6,879 | 132.4K | +5% | $0 |
| D | 2022-02-24 | 2022-02-22 | LAB | JOG VIKRAM | CFO | F - Tax | $3.62 | -2,825 | 134.2K | -2% | -$10.2K |
| DM | 2022-02-24 | 2022-02-22 | LAB | McCracken Colin | Chief Commercial Off | M - OptEx | $0.00 | +6,520 | 63.9K | +11% | $0 |
| D | 2022-02-24 | 2022-02-22 | LAB | McCracken Colin | Chief Commercial Off | F - Tax | $3.62 | -3,740 | 65.1K | -5% | -$13.5K |
| D | 2022-02-24 | 2022-02-22 | LAB | Linthwaite Stephen Christopher | Pres, CEO | F - Tax | $3.62 | -12.5K | 328.5K | -4% | -$45.1K |
| DM | 2022-02-24 | 2022-02-22 | LAB | Linthwaite Stephen Christopher | Pres, CEO | M - OptEx | $0.00 | +22.4K | 326.3K | +7% | $0 |
| D | 2022-02-24 | 2022-02-22 | LAB | Khadder Nicholas | SVP, Gen. Counsel, Sec | F - Tax | $3.62 | -2,269 | 82.4K | -3% | -$8,214 |
| D | 2022-02-24 | 2022-02-22 | LAB | Khadder Nicholas | SVP, Gen. Counsel, Sec | M - OptEx | $0.00 | +4,062 | 84.7K | +5% | $0 |
| D | 2022-02-24 | 2022-02-22 | LAB | Kreger Bradley Allen | SVP, Gbl Ops | F - Tax | $3.62 | -3,184 | 91.3K | -3% | -$11.5K |
| DM | 2022-02-24 | 2022-02-22 | LAB | Kreger Bradley Allen | SVP, Gbl Ops | M - OptEx | $0.00 | +7,753 | 91.4K | +9% | $0 |
| DM | 2021-11-24 | 2021-11-20 | LAB | Linthwaite Stephen Christopher | Pres, CEO | M - OptEx | $0.00 | +22.4K | 318.8K | +8% | $0 |
| D | 2021-11-24 | 2021-11-20 | LAB | Linthwaite Stephen Christopher | Pres, CEO | F - Tax | $4.49 | -11.3K | 315.2K | -3% | -$50.7K |
| D | 2021-11-24 | 2021-11-20 | LAB | Kreger Bradley Allen | SVP, Gbl Ops | F - Tax | $4.49 | -2,680 | 86.7K | -3% | -$12.0K |
| DM | 2021-11-24 | 2021-11-20 | LAB | Kreger Bradley Allen | SVP, Gbl Ops | M - OptEx | $0.00 | +7,751 | 84.8K | +10% | $0 |
| DM | 2021-11-24 | 2021-11-20 | LAB | JOG VIKRAM | CFO | M - OptEx | $0.00 | +6,877 | 130.1K | +6% | $0 |
| D | 2021-11-24 | 2021-11-20 | LAB | JOG VIKRAM | CFO | F - Tax | $4.49 | -2,378 | 130.2K | -2% | -$10.7K |
| D | 2021-11-24 | 2021-11-20 | LAB | Khadder Nicholas | SVP, Gen. Counsel, Sec | F - Tax | $4.49 | -2,014 | 79.2K | -2% | -$9,043 |
| D | 2021-11-24 | 2021-11-20 | LAB | Khadder Nicholas | SVP, Gen. Counsel, Sec | M - OptEx | $0.00 | +4,063 | 81.2K | +5% | $0 |
| DM | 2021-11-24 | 2021-11-20 | LAB | McCracken Colin | Chief Commercial Off | M - OptEx | $0.00 | +6,519 | 63.5K | +11% | $0 |
| D | 2021-11-24 | 2021-11-20 | LAB | McCracken Colin | Chief Commercial Off | F - Tax | $4.49 | -3,530 | 62.3K | -5% | -$15.8K |
| D | 2021-08-24 | 2021-08-20 | LAB | Khadder Nicholas | SVP, Gen. Counsel, Sec | F - Tax | $6.53 | -2,013 | 77.2K | -3% | -$13.1K |
| D | 2021-08-24 | 2021-08-20 | LAB | Khadder Nicholas | SVP, Gen. Counsel, Sec | M - OptEx | $0.00 | +4,062 | 79.2K | +5% | $0 |
| DM | 2021-08-24 | 2021-08-20 | LAB | Linthwaite Stephen Christopher | Pres, CEO | M - OptEx | $0.00 | +22.4K | 307.7K | +8% | $0 |
| D | 2021-08-24 | 2021-08-20 | LAB | Linthwaite Stephen Christopher | Pres, CEO | F - Tax | $6.53 | -11.3K | 304.1K | -4% | -$73.7K |
| DM | 2021-08-24 | 2021-08-20 | LAB | McCracken Colin | Chief Commercial Off | M - OptEx | $0.00 | +6,519 | 58.9K | +12% | $0 |
| D | 2021-08-24 | 2021-08-20 | LAB | McCracken Colin | Chief Commercial Off | F - Tax | $6.53 | -3,523 | 59.3K | -6% | -$23.0K |
| D | 2021-08-24 | 2021-08-20 | LAB | Kreger Bradley Allen | SVP, Gbl Ops | F - Tax | $6.53 | -2,680 | 81.7K | -3% | -$17.5K |
| DM | 2021-08-24 | 2021-08-20 | LAB | Kreger Bradley Allen | SVP, Gbl Ops | M - OptEx | $0.00 | +7,753 | 79.7K | +11% | $0 |
| D | 2021-08-24 | 2021-08-20 | LAB | JOG VIKRAM | CFO | F - Tax | $6.53 | -2,378 | 125.7K | -2% | -$15.5K |
Purchase Sale Sale after option exercise All abbreviations